Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

REPH

Recro Pharma (REPH)

Recro Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REPH
DateTimeSourceHeadlineSymbolCompany
2:07PMiHub NewswireFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
06/06/20234:38PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
06/02/20234:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/26/20234:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
05/22/20235:11PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:REPHRecro Pharma Inc
05/19/20234:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/19/20234:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/19/20234:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/19/20234:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/19/20234:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/19/20234:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/18/20235:00PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
05/10/20234:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
05/03/20234:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
04/06/20238:26AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:REPHRecro Pharma Inc
03/24/20234:07PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:REPHRecro Pharma Inc
03/24/20234:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
03/13/20237:40AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
03/01/20235:01PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:REPHRecro Pharma Inc
03/01/20234:58PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:REPHRecro Pharma Inc
03/01/20234:52PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:REPHRecro Pharma Inc
03/01/20234:29PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
02/14/20232:58PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
02/10/20239:09AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
02/02/20235:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
01/20/20234:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
01/05/20234:33PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
01/05/20234:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
01/03/20234:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
12/20/20224:56PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:REPH